[1]
D. H. Rahayu, D. W. Anggrahini, and A. B. Hartopo, “Association between serum endothelin-1 level and major adverse cardiovascular events following percutaneous coronary intervention in stable coronary artery disease ”, InaJBCS, vol. 57, no. 4, Nov. 2025.